Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





COVID-19 Molecular Gene Test Uses Nanosensor Technology to Detect Early and Asymptomatic Infections

By LabMedica International staff writers
Posted on 01 Feb 2022

A molecular gene test based on innovative nanosensor technology could reshape the future of COVID-19 diagnostic testing. More...

IdentifySensors Biologics (Shaker Heights, OH, USA), along with researchers at Purdue University (West Lafayette, IN, USA), has developed the new digital technology that aims to replace 50-year PCR testing for multiple infections, including COVID variants. It has finalized proof-of-concept research for its all-new COVID-19 testing method. IdentifySensors is currently in the commercialization stage with Check4, its testing platform that comprises two parts - a re-useable reader and cartridges that intend to check for several infections and pathogens. The first cartridges are intended to test for COVID and the multiple variants, and then a multiplex cartridge which will test for COVID and influenza A and B.

Check4 intends to be a highly accurate, over-the-counter self-test that is fast, accurate, and affordable. It detects early and asymptomatic infections with the accuracy of a PCR test, but without all the necessary reagents, machines, people, and delays. It is intended to avoid the limitations of current molecular tests such as enzymatic reactions, amplification, sample preservation or sample transportation, which can introduce artifacts and raise the risk of false positives. It is not an inaccurate antigen test. This electronic-based disruptive technology intends to use newly-developed nanosensors, saliva, and a user’s smartphone to disrupt the way testing is done now, and into the future. Using saliva and the user’s smartphone, results will be delivered within minutes. Check4 is easy to use and fast, accurate, and affordable. Future intended tests include MRSA, Lyme, Hep C and B, foodborne pathogens, and more.

“With COVID still raging around the globe, our test is a game-changer,” said Dr. Gregory Hummer, founder of IdentifySensors Biologics. “It’s fast, affordable and intends to provide accurate results withing minutes on your smartphone. Check4 can help us get back to living a more normal life.”

Related Links:
IdentifySensors Biologics 
Purdue University


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Collection and Transport System
PurSafe Plus®
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: GeneseeqPrime analyzes 425 cancer-related genes by next-generation sequencing (Photo courtesy of Geneseeq)

Comprehensive Tumor Profiling Kit Decentralizes and Standardizes Oncology Testing

Cancer remains one of the leading global health burdens, with accurate and timely tumor profiling critical to guiding treatment decisions. Traditional approaches often struggle to capture the full range... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.